Related Experiment Video
Updated: Jul 5, 2025
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure
Izza Shahid1, Muhammad Shahzeb Khan2, Gregg C Fonarow3
1Division of Preventive Cardiology, Houston Methodist Academic Institute, Houston, TX, USA.
Insights
Despite evidence, guideline-directed medical therapy (GDMT) for heart failure (HF) is underutilized due to patient, provider, and system barriers. Novel strategies are needed to improve GDMT delivery and patient outcomes.
Area of Science:
- Cardiology
- Implementation Science
- Health Services Research
Background:
- Heart failure (HF) remains a leading cause of mortality and hospitalization globally.
- Guideline-directed medical therapy (GDMT) significantly improves outcomes for HF patients.
- Despite strong evidence, significant gaps exist in the initiation and titration of GDMT for eligible heart failure patients.
Purpose of the Study:
- To review the current utilization of GDMT in heart failure.
- To identify multifactorial barriers hindering optimal GDMT implementation.
- To propose novel strategies for enhancing GDMT delivery in routine clinical practice.
Main Methods:
- This review synthesizes current literature on GDMT implementation in heart failure.
- It examines patient, healthcare professional, and institutional challenges.
- Various contemporary implementation strategies are discussed.
Main Results:
- Significant gaps persist in GDMT initiation and dose titration for heart failure.
- Barriers include patient-related factors, healthcare professional inertia, and systemic issues.
- Numerous implementation strategies, including rapid in-hospital initiation and EHR-integrated interventions, have emerged.
Conclusions:
- Optimizing GDMT delivery is critical to reduce heart failure morbidity and mortality.
- Addressing multifactorial barriers requires multifaceted implementation strategies.
- Novel approaches are essential to improve the uptake and effectiveness of GDMT in heart failure care.
Abstract:
Despite robust scientific evidence and strong guideline recommendations, there remain significant gaps in initiation and dose titration of guideline-directed medical therapy (GDMT) for heart failure (HF) among eligible patients. Reasons surrounding these gaps are multifactorial, and largely attributed to patient, healthcare professionals, and institutional challenges. Concurrently, HF remains a predominant cause of mortality and hospitalization, emphasizing the critical need for improved delivery of therapy to patients in routine clinical practice. To optimize GDMT, various implementation strategies have emerged in the recent decade such as in-hospital rapid initiation of GDMT, improving patient adherence, addressing clinical inertia, improving affordability, engagement in quality improvement registries, multidisciplinary clinics, and EHR-integrated interventions. This review highlights the current use and barriers to optimal utilization of GDMT, and proposes novel strategies aimed at improving GDMT in HF.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:22Heart Failure Drugs: β-Blockers
01:26Heart Failure Drugs: Inotropic Agents
01:22Heart Failure Drugs: Diuretics
01:17Pathophysiology of Heart Failure
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...